Jaiprakash Associates Limited

Transcription

1 Jaiprakash Associates Limited April 26, 2017 Ratings Facilities/Instruments Amount (Rs. crore) Rating 1 Rating Action Long-term Bank Facilities 21, (reduced from 21,786.30) Short-term Bank Facilities 2, (reduced from 2,776.31) CARE D (Single D) CARE D (Single D) Long-term/Short-term Bank Facilities 5, (enhanced from 5,387.97) CARE D/CARE D (Single D/Single D) Total Facilities 29, (Rupees Twenty Nine Thousand Two Hundred Fifteen crore and Twenty lakh only) Long-term Non- (aggregate) IV, VIII, X, XII, XIII 1, (Rupees One Thousand Seven Hundred Forty Nine crore and Twenty Five lakh only) CARE D (Single D) Long-term Non- XI - - Withdrawn* *CARE has withdrawn the rating assigned to the 10.75% Non- Debenture issue of Jaiprakash Associates Limited with immediate effect, as the company has repaid the aforementioned NCD issue in full and there is no amount outstanding under the said issue as on date. Details of instruments/facilities in Annexure-1 Detailed Rationale & Key Rating Drivers The ratings of the bank facilities and instruments of Jaiprakash Associates Ltd (JAL) continue to factor in delays in debt servicing by the company due to its weak liquidity. Detailed description of the key rating drivers Key Rating Weaknesses Weak financial performance in FY16 and 9MFY17 During FY16 (standalone), the company s net loss stood at Rs.3, crore on total operating income of Rs.8, crore as against net loss of Rs.1, crore on total operating income of Rs.11, crore in FY15 (refers to the period April 1 to March 31). During 9MFY17 (unaudited), the company reported net loss of Rs.2, crore on total operating income of Rs.4, crore. On account of deterioration in the company s financial performance and delay in receipt of funds through sale of assets; the liquidity position of the company has continued to remain weak, leading to ongoing delays in debt servicing. Key Rating Strengths Sale of cement plants The scheme of arrangement between JAL and Ultratech Cement Ltd for sale of part of JAL s cement business for has been sanctioned by the National Company Law Tribunal, Allahabad Bench. Also, the company has entered into a binding offer to sell its 74% stake in Bhilai Jaypee Cement Ltd and Nigrie cement unit of Jaiprakash Power Ventures Ltd to Orient Cement Ltd. Analytical approach: Standalone 1 Complete definitions of the ratings assigned are available at and in other CARE publications. 1 Credit Analysis & Research Limited

2 Applicable Criteria Criteria on assigning Outlook to Credit Ratings CARE s Policy on Default Recognition Criteria for Short Term Instruments Rating Methodology Manufacturing Companies Financial ratios Non-Financial Sector Policy on Withdrawal of ratings About the Company JAL is the flagship company of the Jaypee group and is engaged in engineering and construction, cement, real estate and hospitality businesses. JAL is one of the leading cement manufacturers in India with JAL s and its subsidiaries installed capacity of about 28 million tonnes per annum (MTPA) and under implementation capacity of around 5 MTPA on a consolidated basis as on March 31, JAL is also engaged in the construction business in the field of civil engineering, design and construction of hydro-power, river valley projects. JAL is also undertaking power generation, power transmission, real estate, road BOT and fertilizer businesses through its various subsidiaries/spvs. Status of non-cooperation with previous CRA: Not Applicable Any other information: Not Applicable Rating History for last three years: Please refer Annexure-2 Note on complexity levels of the rated instrument: CARE has classified instruments rated by it on the basis of complexity. This classification is available at Investors/market intermediaries/regulators or others are welcome to write to care@careratings.com for any clarifications. Analyst Contact: Name: Mr Gautam Bafna Tel: Mobile: gautam.bafna@careratings.com **For detailed Rationale Report and subscription information, please contact us at About CARE Ratings: CARE Ratings commenced operations in April 1993 and over two decades, it has established itself as one of the leading credit rating agencies in India. CARE is registered with the Securities and Exchange Board of India (SEBI) and also recognized as an External Credit Assessment Institution (ECAI) by the Reserve Bank of India (RBI). CARE Ratings is proud of its rightful place in the Indian capital market built around investor confidence. CARE Ratings provides the entire spectrum of credit rating that helps the corporates to raise capital for their various requirements and assists the investors to form an informed investment decision based on the credit risk and their own risk-return expectations. Our rating and grading service offerings leverage our domain and analytical expertise backed by the methodologies congruent with the international best practices. Disclaimer CARE s ratings are opinions on credit quality and are not recommendations to sanction, renew, disburse or recall the concerned bank facilities or to buy, sell or hold any security. CARE has based its ratings/outlooks on information obtained from sources believed by it to be accurate and reliable. CARE does not, however, guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. Most entities whose bank facilities/instruments are rated by CARE have paid a credit rating fee, based on the amount and type of bank facilities/instruments. In case of partnership/proprietary concerns, the rating /outlook assigned by CARE is based on the capital deployed by the partners/proprietor and the financial strength of the firm at present. The rating/outlook may undergo change in case of withdrawal of capital or the unsecured loans brought in by the partners/proprietor in addition to the financial performance and other relevant factors. 2 Credit Analysis & Research Limited

3 Annexure-1: Details of Instruments/Facilities Name of the Date of Instrument Issuance Term Loan-Long Term Non-fund-based- LT/ST Fund-based-Long Term Fund-based - ST- Bills discounting/ Bills purchasing Fund-based - ST- Term loan Fund-based - ST- Working Capital Demand loan -Non -Non -Non -Non -Non -Non Coupon Rate Maturity Date Size of the Issue (Rs. crore) - - Mar CARE D CARE D CARE D CARE D - - Jun CARE D CARE D Oct % Mar CARE D Jul % Jul CARE D Oct % Oct CARE D Jul % Jul CARE D Rating assigned along with Rating Outlook Withdrawn 60 cr Aug cr Nov cr 11.80% 30 cr 12.40% 60 cr Aug cr Nov CARE D Annexure-2: Rating History of last three years Sr. Name of the Current Ratings No. Instrument/Bank Facilities Type 1. -Non Amount Outstanding (Rs. crore) Rating Date(s) & Date(s) & LT CARE D - 1)CARE D Rating history Date(s) & Date(s) & Non LT )Withdrawn (12-Nov-14) 2)CARE A 3. -Non LT )Withdrawn 1)CARE D (23-Jul-15) 2)CARE BB 1)CARE BBB- (17-Dec-14) 2)CARE A- 3 Credit Analysis & Research Limited

4 4. Term Loan-Long Term LT CARE D - 1)CARE D 5. Non-fund-based-LT/ST LT/ST CARE D - 1)CARE D 1)CARE D / 1)CARE BBB- / CARE D CARE A3 / / CARE A4 CARE A2 / CARE A1 6. -Non LT CARE D - 1)CARE D 7. -Non LT )Withdrawn (12-Nov-14) 2)CARE A 8. -Non 9. -Non 10. Fund-based-Long Term 11. Fund-based - ST-Bills discounting/ Bills purchasing LT CARE D - 1)CARE D LT )CARE D LT CARE D - 1)CARE D ST CARE D - 1)CARE D 1)CARE D 1)CARE A3 2)CARE A4 2)CARE A2 1 4 Credit Analysis & Research Limited

5 12. -Non 13. Fund-based - ST-Term loan 14. Fund-based - ST- Working Capital Demand loan LT CARE D - 1)CARE D ST CARE D - 1)CARE D ST CARE D - 1)CARE D 1)CARE D 1)CARE A3 2)CARE A4 2)CARE A2 1 1)CARE D 1)CARE A3 2)CARE A4 2)CARE A Commercial Paper ST )Withdrawn (12-Nov-14) 2)CARE A1 (08-Jul-14) 16. -Non LT CARE D - 1)CARE D 5 Credit Analysis & Research Limited

6 CONTACT Head Office Mumbai Mr. Mehul Pandya Cell: Mr. Saikat Roy Cell: saikat.roy@careratings.com CREDIT ANALYSIS & RESEARCH LIMITED Corporate Office: 4th Floor, Godrej Coliseum, Somaiya Hospital Road, Off Eastern Express Highway, Sion (East), Mumbai Tel: Fax: care@careratings.com AHMEDABAD Mr. Deepak Prajapati 32, Titanium, Prahaladnagar Corporate Road, Satellite, Ahmedabad Cell: Tel: deepak.prajapati@careratings.com BENGALURU Mr. Deepak Prajapati Unit No , 11th Floor, Prestige Meridian II, No. 30, M.G. Road, Bangalore Cell: Tel: , deepak.prajapati@careratings.com CHANDIGARH Mr. Sajan Goyal SCF No , First Floor, Phase 11, Sector 65, Mohali Chandigarh Cell: Tel: / 09 sajan.goyal@careratings.com CHENNAI Mr. V Pradeep Kumar Unit No. O-509/C, Spencer Plaza, 5th Floor, No. 769, Anna Salai, Chennai Cell: Tel: / pradeep.kumar@careratings.com COIMBATORE Mr. V Pradeep Kumar T-3, 3rd Floor, Manchester Square Puliakulam Road, Coimbatore Tel: / pradeep.kumar@careratings.com HYDERABAD Mr. Ramesh Bob 401, Ashoka Scintilla, , Himayat Nagar, Hyderabad Cell : Tel: ramesh.bob@careratings.com JAIPUR Mr. Nikhil Soni 304, Pashupati Akshat Heights, Plot No. D-91, Madho Singh Road, Near Collectorate Circle, Bani Park, Jaipur Cell: Tel: / 14 nikhil.soni@careratings.com KOLKATA Ms. Priti Agarwal 3rd Floor, Prasad Chambers, (Shagun Mall Bldg.) 10A, Shakespeare Sarani, Kolkata Cell: Tel: priti.agarwal@careratings.com NEW DELHI Ms. Swati Agrawal 13th Floor, E-1 Block, Videocon Tower, Jhandewalan Extension, New Delhi Cell: Tel: swati.agrawal@careratings.com PUNE Mr.Pratim Banerjee 9th Floor, Pride Kumar Senate, Plot No. 970, Bhamburda, Senapati Bapat Road, Shivaji Nagar, Pune Cell: Tel: pratim.banerjee@careratings.com CIN - L67190MH1993PLC Credit Analysis & Research Limited